WPWINDACRE PARTNERSHIP LLC

Institutional investor · Portfolio as of Q1 2019

SEC EDGAR SourceSEC Filings

Top Holdings6 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

TRANSDIGM GROUP INC

1.2M$530.7M29.5%$336.960.00%
1 qtr
New
100
NLSNNLSNDelisted

NIELSEN HLDGS PLC

17.3M$409.9M22.8%
1 qtr
New
99

MOODY'S CORP

1.5M$270M15.0%$169.880.00%
1 qtr
New
98

VISA INC-CLASS A SHARES

1.3M$209.6M11.7%$148.120.00%
1 qtr
New
97
SCSCDelisted

SANTANDER CONSUMER USA HOLDINGS

9M$189.5M10.6%
1 qtr
New
97

NEXSTAR MEDIA GROUP INC

1.7M$186.5M10.4%$88.530.00%
1 qtr
New
97
$1.8B
AUM
6
Positions
Q1 2019
Filing
Rating · 3.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q1'19
New100%Increased0%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

WINDACRE PARTNERSHIP LLC manages $1.8B across 6 positions as of Q1 2019. Top holdings: TDG (29.5%), NLSN (22.8%), MCO (15.0%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 3/5.0.

Q1 2019 Summary

Active quarter - 6 new positions, 0 exits, 0 increased. Top move: TDG (NEW, conviction 100). Portfolio: $1.8B across 6 positions.

Top holdings by portfolio weight

Total AUM$2B
TDG29.54%
NLSN22.82%
MCO15.03%
V11.67%
SC10.55%
NXST10.38%

Portfolio allocation by GICS sector

Sectors4
Unknown33.37%
Industrials29.54%
Financial Services26.70%
Communication Services10.38%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown, Industrials, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track RecordNo data
Conviction55
Concentration100
Checking access…

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
SAPSAPSAP SE-SPONSORED ADR
Q3 2025 Q2 2026+3.4M shares+$367.5M
2Q
EXPEEXPEEXPEDIA GROUP INC
Q1 2026 Q2 2026+1.6M shares+$334M
2Q
ROPROPROPER INDUSTRIES INC
Q1 2026 Q2 2026+5.5M shares+$1.5B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used